1. Home
  2. NBTX vs CCNE Comparison

NBTX vs CCNE Comparison

Compare NBTX & CCNE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NBTX
  • CCNE
  • Stock Information
  • Founded
  • NBTX 2003
  • CCNE 1865
  • Country
  • NBTX France
  • CCNE United States
  • Employees
  • NBTX N/A
  • CCNE N/A
  • Industry
  • NBTX Biotechnology: Pharmaceutical Preparations
  • CCNE Major Banks
  • Sector
  • NBTX Health Care
  • CCNE Finance
  • Exchange
  • NBTX Nasdaq
  • CCNE Nasdaq
  • Market Cap
  • NBTX 868.8M
  • CCNE 695.6M
  • IPO Year
  • NBTX 2020
  • CCNE N/A
  • Fundamental
  • Price
  • NBTX $27.75
  • CCNE N/A
  • Analyst Decision
  • NBTX Strong Buy
  • CCNE Hold
  • Analyst Count
  • NBTX 1
  • CCNE 1
  • Target Price
  • NBTX $8.00
  • CCNE $29.00
  • AVG Volume (30 Days)
  • NBTX 162.1K
  • CCNE 145.6K
  • Earning Date
  • NBTX 09-30-2025
  • CCNE 10-20-2025
  • Dividend Yield
  • NBTX N/A
  • CCNE 3.02%
  • EPS Growth
  • NBTX N/A
  • CCNE 2.16
  • EPS
  • NBTX N/A
  • CCNE 2.38
  • Revenue
  • NBTX $11,930,711.00
  • CCNE $224,762,000.00
  • Revenue This Year
  • NBTX N/A
  • CCNE $17.68
  • Revenue Next Year
  • NBTX $114.97
  • CCNE $30.32
  • P/E Ratio
  • NBTX N/A
  • CCNE $10.03
  • Revenue Growth
  • NBTX N/A
  • CCNE 4.79
  • 52 Week Low
  • NBTX $2.76
  • CCNE $19.32
  • 52 Week High
  • NBTX $30.35
  • CCNE $29.29
  • Technical
  • Relative Strength Index (RSI)
  • NBTX 66.10
  • CCNE 50.65
  • Support Level
  • NBTX $23.31
  • CCNE $23.47
  • Resistance Level
  • NBTX $29.72
  • CCNE $25.15
  • Average True Range (ATR)
  • NBTX 2.12
  • CCNE 0.75
  • MACD
  • NBTX 0.66
  • CCNE -0.01
  • Stochastic Oscillator
  • NBTX 80.80
  • CCNE 52.54

About NBTX Nanobiotix S.A.

Nanobiotix SA is a clinical-stage biotechnology company that has one operating segment, which focuses on developing product candidates that use its proprietary nanotechnology to transform cancer treatment by increasing the efficacy of radiotherapy. The company develops NanoXray products to help patients receiving radiotherapy by magnifying the effect of radiotherapy within tumor cells without increasing the dose to surrounding healthy tissues. Its product candidate is NBTXR3, a preclinical research program for cancer immunotherapies.

About CCNE CNB Financial Corporation

CNB Financial Corp is providing integrated financial solutions, which create value for both consumers and businesses. These solutions encompass deposit accounts, private banking, real estate, commercial, industrial, residential and consumer loans and lines of credit, credit cards, treasury services, online banking, mobile banking, merchant credit card processing, remote deposit and accounts receivable handling. It derives revenue through the operations as a full-service bank engaging in a full range of banking activities and services, including trust and wealth management services, for individual, business, governmental, and institutional customers. The company branch are located in Pennsylvania, Ohio, New York and Virginia.

Share on Social Networks: